Stimcell Energetics (STME) Profit After Tax Growth (5y) (2016 - 2026)
Stimcell Energetics (STME) Profit After Tax Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 15.14% |
| Nov 30, 2025 | -9.52% |
| Aug 31, 2025 | -0.58% |
| May 31, 2025 | -6.07% |
| Feb 28, 2025 | 16.74% |
| Nov 30, 2024 | 14.37% |
| Aug 31, 2024 | 23.31% |
| May 31, 2024 | 2.78% |
| Feb 29, 2024 | 18.11% |
| Nov 30, 2023 | 12.94% |
| Aug 31, 2023 | 20.52% |
| May 31, 2023 | 35.32% |
| Feb 28, 2023 | 18.66% |
| Nov 30, 2022 | 4.67% |
| Aug 31, 2022 | 28.59% |
| May 31, 2022 | 29.48% |
| Feb 28, 2022 | 15.49% |
| Nov 30, 2021 | 31.97% |
| Aug 31, 2021 | 8.89% |
| May 31, 2021 | -4.17% |